Position in ALEC
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$312,489
+$126,209 QoQ
Shares Held
145,344
+21.7% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Derivatives in ALEC
reported options exposure · as of Jun 30, 2020CallValue
$733,200
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. ALEC ranks #307 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ALEC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $312,489 | 145,344 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $186,280 | 119,411 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $682,276 | 230,499 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $58,650 | 41,893 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $102,146 | 83,046 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $223,227 | 118,110 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $544,996 | 116,952 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $479,809 | 105,685 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,381,505 | 229,486 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,425,961 | 178,692 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $516,338 | 79,682 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $547,156 | 91,041 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $695,830 | 112,412 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,551,525 | 168,096 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $337,797 | 35,708 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $835,233 | 82,208 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,160,478 | 221,788 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,455,776 | 167,350 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,223,347 | 141,251 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $317,302 | 15,233 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,255,990 | 62,363 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $107,634 | 7,114 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $79,012 | 7,500 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $733,200 | 30,000 | Call | Defined | 2020-07-31 | |
| 2020-06-30 | $186,257 | 7,621 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $298,608 | 12,375 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||